Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...

Three years ago, if you had asked any security professional or KYC specialist in the financial services industry about the ...

Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer ...

Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

Have you had a peak experience lately, replete with great happiness and personal fulfillment? If so, you've probably found ...

Ministry of Information and Broadcasting highlights India’s AI push across Aadhaar, e-Sankhyiki, BharatGen, and agriculture ...

Oncology leaders appearing in Atlanta, Georgia, including several from Winship Cancer Institute from Emory University School of Medicine, show how NGS biomarkers and MRD reshape NSCLC and hematology ...

The American Veterinary Medical Association’s Professional Liability Insurance Trust evaluates reported incidents involving ...

Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment TOKYO and CAMBRIDGE, Mass., Mar 23, 2026 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that new ...